{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-014467","form_type":"8-K","ticker":"MD","cik":"0000893949","company_name":"Pediatrix Medical Group, Inc.","filed_at":"2022-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:58.479370+00:00","generated_at":"2026-06-24T04:42:55.063895+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Pediatrix Q2 adjusted EPS $0.47 vs $0.41 YoY; revenue up 2.7%; FY22 EBITDA outlook reaffirmed","bullets":["GAAP EPS $0.36 flat YoY; adjusted EPS $0.47 vs $0.41 on revenue of $486M (+2.7%).","Same-unit revenue down 1.3%; volume up 0.6% offset by reimbursement decline of 1.9%.","Adjusted EBITDA flat at $65.6M; FY22 outlook reaffirmed at $260-270M.","Repurchased 3.3M shares for $64.4M in Q2; total debt $800M after refinancing.","Interest expense fell to $8.4M from $16.9M due to Q1 refinancing."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-014467","json":"https://secwatch.observer/filing/0000950170-22-014467.json","markdown":"https://secwatch.observer/filing/0000950170-22-014467.md","text":"https://secwatch.observer/filing/0000950170-22-014467.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/893949/000095017022014467/0000950170-22-014467-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/893949/000095017022014467/md-20220804.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T04:42:55.063895+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}